To correlate the elevated CD8+ T cell numbers with putative therapeutic treatment effects (see below), we considered the possibility that CD8+ T cells might comprise both CD8+ CD122− effector T cells and CD8+ CD122+ regulatory T cells, as previously demonstrated in other models for genetic neurodegenerative diseases [24]. This evidence concerns the gene IL2RB and Genetic neurodegenerative disease.